Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Biol Interact ; 351: 109750, 2022 Jan 05.
Article in English | MEDLINE | ID: mdl-34813780

ABSTRACT

We have previously synthesized and characterized the chrysin coordination complex with the oxidovanadium(IV) cation (VIVO(chrys)2) and characterized in ethanolic solution and in solid state. Because suitable single crystals for X-ray diffraction determinations could not be obtained, in the present work, we elucidate the geometrical parameters of this complex by computational methodologies. The optimization and vibrational investigation were carried out both in ethanolic solution and in gas phase. The computational results support the experimentally proposed geometries of the VIVO(chrys)2 complex, thus leading to the conclusion that the complex exists as conformers with trans-octahedral geometry in ethanolic solution and as conformers with cis-octahedral geometry in the solid state. The complex also exists as conformers with trans-octahedral geometry in aqueous media. The active species formed after dissolution in DMSO showed anticancer and antimetastatic behavior in human lung cell line A549 with moderate binding (Kaca. 105 M-1) to bovine serum albumin (BSA). The interaction through hydrogen bonding and van der Waals forces resulted in a spontaneous process. Site marker competitive experiments showed binding sites for chrysin mainly located in site II (subdomain IIIA) and in site I (subdomain IIIA) for the complex. FT-IR spectral measurements showed evidences of the alterations of protein secondary structure in the presence of chrysin and VIVO(chrys)2.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Movement/drug effects , Coordination Complexes/pharmacology , Flavonoids/pharmacology , Serum Albumin, Bovine/metabolism , Vanadium Compounds/pharmacology , A549 Cells , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Binding Sites , Cattle , Cell Survival/drug effects , Coordination Complexes/chemistry , Coordination Complexes/metabolism , Flavonoids/chemistry , Flavonoids/metabolism , Humans , Molecular Structure , Protein Binding , Protein Conformation/drug effects , Reactive Oxygen Species/metabolism , Serum Albumin, Bovine/chemistry , Vanadium Compounds/chemistry , Vanadium Compounds/metabolism
2.
J Inorg Biochem ; 204: 110933, 2020 03.
Article in English | MEDLINE | ID: mdl-31825796

ABSTRACT

We report the synthesis and biological evaluation of a ternary copper complex, [Cu(5HTP)(phen)(H2O)](NO3).2H2O, with the antioxidant agent 5-hydroxytryptophan (5-HTP) and phenanthroline (phen, added to improve its lipophilicity and membrane transport). The crystal structure of the complex was determined by X-ray diffraction methods. The complex showed antioxidant, antimicrobial, antitumor and antimetastatic properties with an adequate safety profile. The interaction of the metal with phen promotes cellular copper accumulation and cytotoxicity on human lung A549 cell line (IC50 = 3.6 µM). Furthermore, the viability of the normal human fetal lung fibroblast cell line (MRC-5) is not altered by the complex. An oxidative stress mechanism for the anticancer effect has been determined: cellular increase of reactive oxygen species (ROS), decrease of the glutathione (GSH) and oxidized GSH (GSSG) ratio and alteration of the mitochondrial potential. The complex also displays antimetastatic activities with inhibition of cell adhesion, invasion and migration. It has not mutagenic behavior and no toxicity on Artemia salina indicating its potential to act as an effective and safety antimicrobial and antitumor drug.


Subject(s)
5-Hydroxytryptophan/chemistry , Antineoplastic Agents/pharmacology , Coordination Complexes/pharmacology , Copper/chemistry , Lung Neoplasms/drug therapy , Phenanthrolines/chemistry , A549 Cells , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/chemistry , Antioxidants/chemistry , Antioxidants/pharmacology , Apoptosis/drug effects , Artemia/drug effects , Cell Movement/drug effects , Cell Proliferation/drug effects , Coordination Complexes/chemistry , Copper/pharmacology , Humans , Phenanthrolines/pharmacology , Toxicity Tests
3.
Biomed Pharmacother ; 111: 414-426, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30594780

ABSTRACT

5-Hydroxy-L-tryptophan (5-HTP) is a serotonin pathway metabolite of L-tryptophan in the brain. In the knowledge that the biological properties of some compounds can be modified upon metal complexation, a new solid metal complex, [Cu(5-hydroxytryptophan)2].H2O (Cu5HTP), has been synthesized and characterized to analyze the modification of some biological properties. The conformational investigations (optimized in gas phase at B3LYP/6-311G** theory level) suggest the coexistence of two conformers of Cu5HTP with cis- and trans- arrangements of the amino acids in the equatorial plane. The trans- Cu5HTP1 complex is the most stable conformer. The complexation led to an enhancement of the antioxidant properties of the ligand. The metal complex also improved the anticancer behavior of the ligand (tested in cancer cell lines derived from human lung (A549), cervix (HeLa) and colon (HCT-116)). It did not show toxicity against either the non-malignant human lung fibroblast (MRC-5) cell line or Artemia salina and did not behave as mutagenic agent (Ames test). Cellular reactive oxygen species production may be one of the possible mechanisms of action. Besides, the metal complex exerted neuroprotective action on cortical neurons from embryonic 18 days rats exposed to glutamate.


Subject(s)
5-Hydroxytryptophan/chemical synthesis , Antineoplastic Agents/chemical synthesis , Antioxidants/chemical synthesis , Copper/chemistry , Cytotoxins/chemical synthesis , Neuroprotective Agents/chemical synthesis , 5-Hydroxytryptophan/pharmacology , A549 Cells , Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Cell Survival/drug effects , Cell Survival/physiology , Copper/pharmacology , Cytotoxins/pharmacology , Dose-Response Relationship, Drug , HCT116 Cells , HeLa Cells , Humans , Neuroprotective Agents/pharmacology
4.
Spectrochim Acta A Mol Biomol Spectrosc ; 198: 212-221, 2018 Jun 05.
Article in English | MEDLINE | ID: mdl-29547823

ABSTRACT

Coumarins (2H-chromen-2-one) are oxygen-containing heterocyclic compounds that belong to the benzopyranones family. In this work we have synthesized different coordination complexes with coumarin-3-carboxylic acid (HCCA), o-phenanthroline (phen) and zinc(II). In the reported [Zn(CCA)2(H2O)2] complex, coumarin-3-carboxylate (CCA) is acting as a bidentate ligand while in the two prepared complexes, [Zn(phen)3]CCA(NO3) (obtained as a single crystal) and [Zn(CCA)2phen].4H2O, CCA is acting as a counterion of the complex cation [Zn(phen)3]+2 or coordinated to the metal center along with phen, respectively. These compounds were characterized on the basis of elemental analysis and thermogravimetry. NMR, FTIR and Raman spectroscopies of the compounds and the CCA potassium salt (KCCA) allow to determine several similarities and differences among them. Finally, their behavior against alkaline phosphatase enzyme and their antimicrobial activities were also measured.


Subject(s)
Anti-Infective Agents/pharmacology , Coordination Complexes/chemistry , Coumarins/chemistry , Phenanthrolines/chemistry , Zinc Compounds/chemistry , Alkaline Phosphatase/chemistry , Alkaline Phosphatase/metabolism , Anti-Infective Agents/chemistry , Coordination Complexes/pharmacology , Crystallography, X-Ray , Drug Evaluation, Preclinical , Magnetic Resonance Spectroscopy , Microbial Sensitivity Tests , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman
5.
J Mol Graph Model ; 76: 181-191, 2017 09.
Article in English | MEDLINE | ID: mdl-28734206

ABSTRACT

Flavonoids are a large group of polyphenolic compounds ubiquitously present in plants. They are important components of human diet. They are recognized as potential drug candidates to be used in the treatment and prevention of a lot of pathological disorders, due to their protective effects. Baicalin (7-glucuronic acid 5, 6-dihydroxyflavone) is one of the main single active constituents isolated from the dried roots of Scutellaria baicalensis Georgi. The great interest on this flavonoid is due to its various pharmacological properties, such as antioxidant, antimicrobial, anti-inflammatory, anticancer and so on, and its high accumulation in the roots of S. baicalensis. The aim of our work was to analyze the geometric and electronic properties of baicalin conformers (BCL), thus performing a complete search on the conformational space of this flavonoid in gas phase and in aqueous solution. The results indicate that the conformational space of baicalin is formed by eight conformers in gas phase and five conformers in aqueous solution optimized at B3LYP/6-311++G** theory level. BCLa2TT and BCLa1TT conformers have low stability in gas phase and very high stability in aqueous solution. This variation is related to a modification in the τ1 angle that represents the relative position of the glucuronide unit respect to the central rings of the flavan nucleus (A and C). This modification was successfully explained by examining the changes in the hydrogen bond (HB) interactions that occur in the region around the hydroxyl group located in position 6 of ring A. Besides, the molecular electrostatic potential (MEP) and frontier molecular orbital (FMO) analyses indicate that BCLa2TT and BCLa1TT conformers are the most favorable conformers for interacting with positively charged species (such as metal ions) in aqueous media (such as biological fluids).


Subject(s)
Flavonoids/chemistry , Glucuronides/chemistry , Hydrogen Bonding , Molecular Conformation , Plant Extracts/chemistry , Scutellaria baicalensis/chemistry , Static Electricity , Water/chemistry
6.
J Inorg Biochem ; 166: 150-161, 2017 01.
Article in English | MEDLINE | ID: mdl-27863301

ABSTRACT

Based on the known antioxidant effect of flavonoids, baicalin (baic) found in roots of Scutellaria has been selected. Its coordination complex with the oxidovanadium(IV) cation, Na4[VO(baic)2].6H2O (VIVO(baic)), was synthesized at pH9 in ethanol and characterized by physicochemical methods. Spectrophotometric studies at pH9 showed a ligand: metal stoichiometry of 2:1. By vibrational spectroscopy a coordination mode through the cis 5-OH and 6-OH deprotonated groups is inferred. EPR spectroscopy shows an environment of four aryloxide (ArO-) groups in the equatorial plane of the VO moiety, both in solution and in the solid complex. The antioxidant capacity against superoxide and peroxyl radicals of VIVO(baic) resulted greater than for baicalin and correlated with previous results obtained for other VOflavonoid complexes. The coordination mode produces delocalization of the electron density and the stabilization of the radical formed by interaction with external radicals. The complex and the ligand displayed no toxic (Artemia salina test) and no mutagenic (Ames test) effects. The complex improved the ability of the ligand to reduce cell viability of human lung cancer cell lines (A549) generating reactive oxygen species (ROS) in cells, being this effect reversed by pre-incubation of the cells with antioxidants such as vitamins C and E. The addition of NAC (N-acetyl-l-cysteine, a sequestering agent of free radicals) suppresses the anticancer effect, confirming the oxidative stress mechanism. The complex interacted with bovine serum albumin (BSA) with stronger binding than baicalin and the mechanisms involved H bonding and van der Waals interactions.


Subject(s)
Antineoplastic Agents , Antioxidants , Coordination Complexes , Flavonoids , Lung Neoplasms/drug therapy , Vanadates , A549 Cells , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antioxidants/chemical synthesis , Antioxidants/chemistry , Antioxidants/pharmacology , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , Coordination Complexes/pharmacology , Drug Screening Assays, Antitumor , Flavonoids/chemistry , Flavonoids/pharmacology , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Reactive Oxygen Species/metabolism , Vanadates/chemical synthesis , Vanadates/chemistry , Vanadates/pharmacology
7.
Chem Biol Interact ; 249: 46-55, 2016 Apr 05.
Article in English | MEDLINE | ID: mdl-26952715

ABSTRACT

To improve the antidepressant action of sertraline a new salt with coumarin-3-carboxylate anion (SerH-CCA) has been synthesized by two different methods and characterized by FTIR spectroscopy and structural determinations by X-ray diffraction methods. The new salt is stabilized by strong intermolecular H-bonds involving the protonated amine group of SerH and the deprotonated carboxylate group of CCA. These findings can be correlated with the interpretation of the infrared spectrum. The salt, sertraline (SerHCl) and the sodium salt of coumarin-3-carboxylate (NaCCA) were orally administered male Wistar rats (10 mg/kg, based on sertraline). Rats were evaluated in separate groups by means of the forced swimming (FST). SerH-CCA produced antidepressant effects in a magnitude that exceeded SerHCl individual effects. None of these treatments affected activity levels by the open field OFT tests. We have also determined that the ion pair also improve the binding to bovine serum albumin (BSA) of the drug but retain its antimicrobial activity. It is reasonable to conclude that the replacement of chloride anion by a large organic anion in sertraline strengthens the pharmacological action of the native drug, binding to BSA with higher activity and retaining the antimicrobial activity of the antidepressant compound.


Subject(s)
Antidepressive Agents/chemistry , Antidepressive Agents/pharmacokinetics , Coumarins/chemistry , Sertraline/chemistry , Sertraline/pharmacokinetics , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacokinetics , Anti-Infective Agents/pharmacology , Antidepressive Agents/pharmacology , Biological Availability , Crystallization/methods , Depression/drug therapy , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Sertraline/pharmacology , Swimming/physiology , X-Ray Diffraction/methods
8.
Chem Biol Interact ; 229: 64-72, 2015 Mar 05.
Article in English | MEDLINE | ID: mdl-25641192

ABSTRACT

It has been reported that various metal coordination compounds have improved some biological properties. A high activity of acid phosphatase (AcP) is associated to several diseases (osteoporosis, Alzheimer's, prostate cancer, among others) and makes it a target for the development of new potential inhibitors. Anti-thyroid agents have disadvantageous side effects and the scarcity of medicines in this area motivated many researchers to synthesize new ones. Several copper(II) complexes have shown antifungal activities. In this work we presented for a first time the inhibition of AcP and the anti-thyroid activity produced by methimazole-Cu(II) complexes. Cu-Met ([Cu(MeimzH)2(H2O)2](NO3)2·H2O) produces a weak inhibition action while Cu-Met-phen ([Cu(MeimzH)2(phen)(H2O)2]Cl2) shows a strong inhibition effect (IC50 = 300 µM) being more effective than the reported behavior of vanadium complexes. Cu-Met-phen also presented a fairly good anti-thyroid activity with a formation constant value, Kc=1.02 × 10(10)M(-1) being 10(6) times more active than methimazole (Kc = 4.16 × 10(4)M(-1)) in opposition to Cu-Met which presented activity (Kc=9.54 × 10(3)M(-1)) but in a lesser extent than that of the free ligand. None of the complexes show antifungal activity except Cu-phen (MIC = 11.71 µgmL(-1) on Candidaalbicans) which was tested for comparison. Besides, albumin interaction experiments denoted high affinity toward the complexes and the calculated binding constants indicate reversible binding to the protein.


Subject(s)
Acid Phosphatase/antagonists & inhibitors , Antifungal Agents/pharmacology , Antithyroid Agents/pharmacology , Coordination Complexes/pharmacology , Copper/pharmacology , Methimazole/pharmacology , Serum Albumin, Bovine/metabolism , Acid Phosphatase/metabolism , Animals , Antifungal Agents/chemistry , Antithyroid Agents/chemistry , Candida/drug effects , Candidiasis/drug therapy , Cattle , Coordination Complexes/chemistry , Copper/chemistry , Humans , Methimazole/chemistry , Protein Conformation/drug effects , Serum Albumin, Bovine/chemistry
9.
Inorg Chem ; 53(11): 5724-37, 2014 Jun 02.
Article in English | MEDLINE | ID: mdl-24823617

ABSTRACT

A new Cu(II) complex with the antihypertensive drug telmisartan, [Cu8Tlm16]·24H2O (CuTlm), was synthesized and characterized by elemental analysis and electronic, FTIR, Raman and electron paramagnetic resonance spectroscopy. The crystal structure (at 120 K) was solved by X-ray diffraction methods. The octanuclear complex is a hydrate of but otherwise isostructural to the previously reported [Cu8Tlm16] complex. [Cu8Tlm16]·24H2O crystallizes in the tetragonal P4/ncc space group with a = b = 47.335(1), c = 30.894(3) Å, Z = 4 molecules per unit cell giving a macrocyclic ring with a double helical structure. The Cu(II) ions are in a distorted bipyramidal environment with a somewhat twisted square basis, cis-coordinated at their core N2O2 basis to two carboxylate oxygen and two terminal benzimidazole nitrogen atoms. Cu8Tlm16 has a toroidal-like shape with a hydrophobic nanometer hole, and their crystal packing defines nanochannels that extend along the crystal c-axis. Several biological activities of the complex and the parent ligand were examined in vitro. The antioxidant measurements indicate that the complex behaves as a superoxide dismutase mimic with improved superoxide scavenger power as compared with native sartan. The capacity of telmisartan and its copper complex to expand human mesangial cells (previously contracted by angiotensin II treatment) is similar to each other. The antihypertensive effect of the compounds is attributed to the strongest binding affinity to angiotensin II type 1 receptor and not to the antioxidant effects. The cytotoxic activity of the complex and that of its components was determined against lung cancer cell line A549 and three prostate cancer cell lines (LNCaP, PC-3, and DU 145). The complex displays some inhibitory effect on the A549 line and a high viability decrease on the LNCaP (androgen-sensitive) line. From flow cytometric analysis, an apoptotic mechanism was established for the latter cell line. Telmisartan and CuTlm show antibacterial and antifungal activities in various strains, and CuTlm displays improved activity against the Staphylococcus aureus strain as compared with unbounded copper(II).


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Antihypertensive Agents/chemical synthesis , Antineoplastic Agents/chemical synthesis , Antioxidants/chemical synthesis , Benzimidazoles/chemistry , Benzoates/chemistry , Copper/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Antihypertensive Agents/chemistry , Antihypertensive Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antioxidants/chemistry , Antioxidants/pharmacology , Apoptosis/drug effects , Bacteria/drug effects , Cell Line , Humans , Microbial Sensitivity Tests , Models, Molecular , Molecular Structure , Nanostructures , Telmisartan
SELECTION OF CITATIONS
SEARCH DETAIL
...